Guillain-Barré syndrome as a parainfectious manifestation of SARS-CoV-2 infection: A case series.

J Clin Neurosci

Shefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran; Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.

Published: January 2021

AI Article Synopsis

Article Abstract

The global SARS-CoV-2 pandemic posed an unprecedented challenge to almost all fields of medicine and Neurology is not an exception. Collecting information about its complications and related conditions will help clinicians to become more confident in managing this disease. Guillain-Barre Syndrome (GBS) is mostly described as a post-infectious phenomenon and its occurrence during acute phase of illness is of interest. GBS has recently been reported during the active phase of COVID-19 for the first time. Severity and fast progression of GBS associated with COVID-19 have also been shown in recent studies. Here we report three cases of GBS during the active phase of COVID-19 with severe symptoms and fast progression to quadriplegia and facial diplegia over 2 days, which led to death in one case due to severe autonomic dysfunction. We suggest SARS-CoV-2 might be associated with rather a severe, rapidly progressive and life-threatening phenotype of GBS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666532PMC
http://dx.doi.org/10.1016/j.jocn.2020.11.013DOI Listing

Publication Analysis

Top Keywords

active phase
8
phase covid-19
8
fast progression
8
gbs
5
guillain-barré syndrome
4
syndrome parainfectious
4
parainfectious manifestation
4
manifestation sars-cov-2
4
sars-cov-2 infection
4
infection case
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!